Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
PaperCitations, authors & open-access status
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 75 citations, 2022 year and hybrid oa status.
75
Citations
2022
Year
hybrid
OA Status